Mitotane
Back to searchMolecule Structure
Scientific Name
Mitotane
Description of the Drug
Mitotane is an adrenal cortex inhibitor used to treat adrenocortical tumors and Cushing’s syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00648
http://www.drugbank.ca/drugs/DB00648
Brand Name(s)
Lysodren, Opddd
Company Owner(s)
Hra Pharma Rare Diseases
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cytochrome P450 11B1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1908 |
| Cytochrome P450 11A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL2033 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4040 | |
| PharmGKB | PA164746157 | |
| Human Metabolome Database | HMDB0014786 | |
| DrugBank | DB00648 | |
| PubChem: Thomson Pharma | 14801378 | |
| PubChem | 4211 | |
| Mcule | MCULE-2068358149 | |
| LINCS | LSM-1451 | |
| Nikkaji | J1.366H | |
| BindingDB | 50239991 | |
| EPA CompTox Dashboard | DTXSID9020372 | |
| DrugCentral | 1820 | |
| Brenda | 55840 | |
| ChemicalBook | CB0392321 | |
| Guide to Pharmacology | 6957 | |
| rxnorm | LYSODREN | MITOTANE |
| ChEBI | 6954 |
